164 related articles for article (PubMed ID: 9446652)
1. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin: platelet factor 4.
Suh JS; Aster RH; Visentin GP
Blood; 1998 Feb; 91(3):916-22. PubMed ID: 9446652
[TBL] [Abstract][Full Text] [Related]
2. Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody.
Li ZQ; Liu W; Park KS; Sachais BS; Arepally GM; Cines DB; Poncz M
Blood; 2002 Feb; 99(4):1230-6. PubMed ID: 11830470
[TBL] [Abstract][Full Text] [Related]
3. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
Visentin GP; Ford SE; Scott JP; Aster RH
J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.
Arepally GM; Kamei S; Park KS; Kamei K; Li ZQ; Liu W; Siegel DL; Kisiel W; Cines DB; Poncz M
Blood; 2000 Mar; 95(5):1533-40. PubMed ID: 10688805
[TBL] [Abstract][Full Text] [Related]
5. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis.
Visentin GP; Moghaddam M; Beery SE; McFarland JG; Aster RH
J Lab Clin Med; 2001 Jul; 138(1):22-31. PubMed ID: 11433225
[TBL] [Abstract][Full Text] [Related]
6. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia.
Ziporen L; Li ZQ; Park KS; Sabnekar P; Liu WY; Arepally G; Shoenfeld Y; Kieber-Emmons T; Cines DB; Poncz M
Blood; 1998 Nov; 92(9):3250-9. PubMed ID: 9787161
[TBL] [Abstract][Full Text] [Related]
7. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
[TBL] [Abstract][Full Text] [Related]
8. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
[TBL] [Abstract][Full Text] [Related]
9. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.
Huynh A; Kelton JG; Arnold DM; Daka M; Nazy I
Nature; 2021 Aug; 596(7873):565-569. PubMed ID: 34233346
[TBL] [Abstract][Full Text] [Related]
10. Fc gamma RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis.
Arepally G; McKenzie SE; Jiang XM; Poncz M; Cines DB
Blood; 1997 Jan; 89(2):370-5. PubMed ID: 9002937
[TBL] [Abstract][Full Text] [Related]
11. Further characterization of antibody and antigen in heparin-induced thrombocytopenia.
Newman PM; Chong BH
Br J Haematol; 1999 Nov; 107(2):303-9. PubMed ID: 10583216
[TBL] [Abstract][Full Text] [Related]
12. Complexes of heparin and platelet factor 4 specifically stimulate T cells from patients with heparin-induced thrombocytopenia/thrombosis.
Bacsi S; De Palma R; Visentin GP; Gorski J; Aster RH
Blood; 1999 Jul; 94(1):208-15. PubMed ID: 10381515
[TBL] [Abstract][Full Text] [Related]
13. Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation.
Johnston I; Sarkar A; Hayes V; Koma GT; Arepally GM; Chen J; Chung DW; López JA; Cines DB; Rauova L; Poncz M
Blood; 2020 Apr; 135(15):1270-1280. PubMed ID: 32077913
[TBL] [Abstract][Full Text] [Related]
14. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
[TBL] [Abstract][Full Text] [Related]
15. Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.
Litvinov RI; Yarovoi SV; Rauova L; Barsegov V; Sachais BS; Rux AH; Hinds JL; Arepally GM; Cines DB; Weisel JW
J Biol Chem; 2013 Nov; 288(46):33060-70. PubMed ID: 24097975
[TBL] [Abstract][Full Text] [Related]
16. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
[TBL] [Abstract][Full Text] [Related]
17. Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation.
Bakchoul T; Assfalg V; Zöllner H; Evert M; Novotny A; Matevossian E; Friess H; Hartmann D; Hron G; Althaus K; Greinacher A; Hüser N
J Thromb Haemost; 2014 Jun; 12(6):871-8. PubMed ID: 24655935
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
[TBL] [Abstract][Full Text] [Related]
19. The epitope specificity of heparin-induced thrombocytopenia.
Horsewood P; Warkentin TE; Hayward CP; Kelton JG
Br J Haematol; 1996 Oct; 95(1):161-7. PubMed ID: 8857955
[TBL] [Abstract][Full Text] [Related]
20. Distinct Binding Characteristics of Pathogenic Anti-Platelet Factor-4/Polyanion Antibodies to Antigens Coated on Different Substrates: A Perspective on Clinical Application.
Nguyen TH; Greinacher A
ACS Nano; 2018 Dec; 12(12):12030-12041. PubMed ID: 30540167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
